Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 35,000 RYTM shares, $850.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 35,000 | $850.1K |
| Feb 13, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 21,650 | n/a |
| Feb 3, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 22,612 | n/a |
| Feb 20, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 5,500 | n/a |
| Feb 14, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale | 600 | $33.8K |
| Feb 12, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 3,437 | n/a |
| Feb 7, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale | 1,733 | $104.1K |
| Feb 5, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,513 | n/a |
| Nov 14, 2024 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 20,622 | $140.2K |
| Mar 22, 2024 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale | 9,169 | $350.4K |